Gene: UGCG
Official Full Name: UDP-glucose ceramide glucosyltransferaseprovided by HGNC
Gene Summary: This gene encodes an enzyme that catalyzes the first glycosylation step in the biosynthesis of glycosphingolipids, which are membrane components containing lipid and sugar moieties. The product of this reaction is glucosylceramide, which is the core structure of many glycosphingolipids. [provided by RefSeq, Dec 2014]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO05673 | UGCG Knockout cell line (HeLa) | Human | UGCG | 1:3~1:6 | Negative | Online Inquiry |
KO05674 | UGCG Knockout cell line (HCT 116) | Human | UGCG | 1:2~1:4 | Negative | Online Inquiry |
KO05675 | UGCG Knockout cell line (HEK293) | Human | UGCG | 1:3~1:6 | Negative | Online Inquiry |
KO05676 | UGCG Knockout cell line (A549) | Human | UGCG | 1:3~1:4 | Negative | Online Inquiry |
UGCG Gene Knockout Cell Lines are specialized cellular models engineered to specifically disrupt the function of the UDP-glucose ceramide glucosyltransferase (UGCG) gene. This gene plays a crucial role in the synthesis of glucosylceramide, which is a key component in glycosphingolipid metabolism. By providing a cellular environment devoid of UGCG activity, these knockout cell lines enable researchers to investigate the gene’s physiological and pathological roles with high precision.
The primary function of the UGCG Gene Knockout Cell Lines lies in their ability to elucidate the consequences of UGCG deficiency on cell biology, signaling pathways, and disease mechanisms. The knockout is typically achieved through innovative CRISPR-Cas9 technology, which allows for precise edits at the genomic level, ensuring a complete loss of gene expression. This results in altered lipid metabolism, thereby providing insights into various diseases, including Gaucher disease, cancer, and neurodegenerative disorders.
Scientifically, these cell lines hold significant importance in both research and clinical settings as they facilitate the study of the complex interplay between lipids and cellular processes. They pave the way for drug discovery and therapeutic interventions targeting UGCG-related pathways. By using these cell lines, researchers can develop comprehensive models that mimic disease states, ultimately leading to improved understanding and potential treatment options.
Compared to alternative models such as wild-type cell lines or chemically induced knockout models, UGCG Gene Knockout Cell Lines offer superior specificity and reproducibility. Their well-defined genetic background minimizes variability, thereby generating more reliable data for hypothesis testing. Additionally, their ease of use in standard laboratory protocols enhances the efficiency of research workflows.
For researchers and clinicians alike, UGCG Gene Knockout Cell Lines represent a valuable tool for advancing knowledge in lipid biology and related diseases. Their unique characteristics empower a deeper exploration of metabolic pathways critical for health and disease. With our deep expertise in cellular and molecular biology, our company ensures the provision of high-quality gene knockout products, designed to meet the rigorous demands of the scientific community.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.